BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32118737)

  • 1. Age, absolute CD4 count, and CD4 percentage in relation to HPV infection and the stage of cervical disease in HIV-1-positive women.
    Chambuso R; Ramesar R; Kaambo E; Murahwa AT; Abdallah MOE; De Sousa M; Denny L; Williamson AL; Gray CM
    Medicine (Baltimore); 2020 Feb; 99(9):e19273. PubMed ID: 32118737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results.
    Harris TG; Burk RD; Palefsky JM; Massad LS; Bang JY; Anastos K; Minkoff H; Hall CB; Bacon MC; Levine AM; Watts DH; Silverberg MJ; Xue X; Melnick SL; Strickler HD
    JAMA; 2005 Mar; 293(12):1471-6. PubMed ID: 15784870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
    Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J
    Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
    Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
    AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitype Infections With Human Papillomavirus: Impact of Human Immunodeficiency Virus Coinfection.
    Massad L; Keller M; Xie X; Minkoff H; Palefsky J; DʼSouza G; Colie C; Villacres M; Strickler H
    Sex Transm Dis; 2016 Oct; 43(10):637-41. PubMed ID: 27631359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.
    Moscicki AB; Ellenberg JH; Vermund SH; Holland CA; Darragh T; Crowley-Nowick PA; Levin L; Wilson CM
    Arch Pediatr Adolesc Med; 2000 Feb; 154(2):127-34. PubMed ID: 10665598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of HPV infection over time in European women who are HIV-1 positive.
    Heard I; Cubie HA; Mesher D; Sasieni P;
    BJOG; 2013 Jan; 120(1):41-9. PubMed ID: 23121095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
    Jain BB; Adhikary T; Sadhukhan PC; Nandi A
    J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women.
    La Ruche G; You B; Mensah-Ado I; Bergeron C; Montcho C; Ramon R; Touré-Coulibaly K; Welffens-Ekra C; Dabis F; Orth G
    Int J Cancer; 1998 May; 76(4):480-6. PubMed ID: 9590121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa.
    Firnhaber C; Van Le H; Pettifor A; Schulze D; Michelow P; Sanne IM; Lewis DA; Williamson AL; Allan B; Williams S; Rinas A; Levin S; Smith JS
    Cancer Causes Control; 2010 Mar; 21(3):433-43. PubMed ID: 19949850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of Cervical Tumor Biopsies for Chromosomal Loss of Heterozygosity (LOH) and Microsatellite Instability (MSI) at the
    Chambuso R; Kaambo E; Denny L; Gray CM; Williamson AL; Migdalska-Sęk M; Agenbag G; Rebello G; Ramesar R
    Front Oncol; 2019; 9():951. PubMed ID: 31681558
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
    Branca M; Costa S; Mariani L; Sesti F; Agarossi A; di Carlo A; Galati M; Benedetto A; Ciotti M; Giorgi C; Criscuolo A; Valieri M; Favalli C; Paba P; Santini D; Piccione E; Alderisio M; De Nuzzo M; di Bonito L; Syrjänen K
    Eur J Gynaecol Oncol; 2004; 25(6):689-98. PubMed ID: 15597844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART.
    Madeddu G; Mameli G; Capobianco G; Babudieri S; Maida I; Bagella P; Rocca G; Cherchi PL; Sechi LA; Zanetti S; Nunnari G; Dessole S; Mura MS
    Eur Rev Med Pharmacol Sci; 2014; 18(8):1277-85. PubMed ID: 24817305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa.
    Taku O; Mbulawa ZZA; Phohlo K; Garcia-Jardon M; Businge CB; Williamson AL
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cytological abnormalities and human papilloma virus infection in women infected with HIV in Southern India.
    Thunga S; Andrews A; Ramapuram J; Satyamoorthy K; Kini H; Unnikrishnan B; Adhikari P; Singh P; Kabekkodu SP; Bhat S; Kadam A; Shetty AK
    J Obstet Gynaecol Res; 2016 Dec; 42(12):1822-1828. PubMed ID: 27641071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual and partner risk factors associated with abnormal cervical cytology among women in HIV-discordant relationships.
    Soh J; Rositch AF; Koutsky L; Guthrie BL; Choi RY; Bosire RK; Gatuguta A; Smith JS; Kiarie J; Lohman-Payne B; Farquhar C
    Int J STD AIDS; 2014 Apr; 25(5):315-24. PubMed ID: 24047885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study.
    Massad LS; Ahdieh L; Benning L; Minkoff H; Greenblatt RM; Watts H; Miotti P; Anastos K; Moxley M; Muderspach LI; Melnick S
    J Acquir Immune Defic Syndr; 2001 Aug; 27(5):432-42. PubMed ID: 11511819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women.
    Minkoff H; Zhong Y; Strickler HD; Watts DH; Palefsky JM; Levine AM; D'Souza G; Howard AA; Plankey M; Massad LS; Burk R
    Infect Dis Obstet Gynecol; 2008; 2008():587082. PubMed ID: 18437233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of abnormal cervical cytology in HIV-infected women testing positive for both human papillomavirus and Epstein-Barr virus in genital tract specimens.
    Cameron JE; Dennis DC; Herrel NR; Chapple AG; Hagensee ME
    Cancer Causes Control; 2020 Apr; 31(4):365-375. PubMed ID: 32112173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.